There are 2 ways of qualifying new products: either manually, using a qualifying field maintained by the user, or automatically through the study of GTIN codes.

Advantages and disadvantages of the 2 methods

A manual qualification of novelties by the user makes it possible to be very precise in the monitoring of novelties and to distinguish minor innovations (ex: technical change code, promotional codes) breakthrough innovations. However, this technique has the drawback of increasing the workload for the user.
An automatic qualification of new features guarantees an exhaustive overview of new features and eliminates the time lag associated with manual qualification. The main drawback of this method is that it does not allow the user to manually exclude certain products in the innovation calculation. This is a high estimate .

Why is automatic product qualfication a high estimate?

Highlighting new features using GTIN code analysis is a high estimate of new features for 2 main reasons:

  • The use of new GTIN codes may meet technical or administrative needs (eg: change in regulatory status, minor product modification, change in production mode) which are not new from a point of view commercial

  • Minor changes to a product (capacity, packaging, promotional code, etc.) do not constitute product innovations as such

Add roadmap

The OpenHealth teams are working on an evolution of the Launch Tracking module allowing the user to manually qualify his novelties

Did this answer your question?